Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Cammie Lesser
Massachusetts General Hospital - Center for Bacterial Pathogenesis
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
37
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Engineered
E. coli
for the Targeted Deposition of Therapeutic Payloads to Sites of Disease
Number of pages: 56
Posted: 10 Jun 2022
Jason Paul Lynch
,
Coral González-Prieto
,
Analise Reeves
,
Urmila Powale
,
Neha Godbole
,
Jacqueline Tremblay
,
Florian Schmidt
,
Hidde Ploegh
,
Jonathan Glickman
,
John Leong
,
Charles Shoemaker
,
Wendy Garrett
and Cammie Lesser
Massachusetts General Hospital - Center for Bacterial Pathogenesis, Massachusetts General Hospital - Center for Bacterial Pathogenesis, Massachusetts General Hospital - Center for Bacterial Pathogenesis, Massachusetts General Hospital - Center for Bacterial Pathogenesis, Massachusetts General Hospital - Center for Bacterial Pathogenesis, Tufts University - Department of Infectious Disease and Global Health, University of Bonn - Institute of Innate Immunity, Harvard University - Boston Children’s Hospital, Harvard University - Department of Pathology, Tufts University - Department of Molecular Biology and Microbiology, Tufts University - Department of Infectious Disease and Global Health, Harvard University - Department of Immunology and Infectious Diseases and Massachusetts General Hospital - Center for Bacterial Pathogenesis
Downloads
37
(960,607)
View PDF
Download
Abstract:
designer probiotic, engineered E coli, type III secretion, inflammatory bowel disease
Feedback